Suppr超能文献

血流导向装置治疗颈内动脉-眼动脉瘤的长期临床效果。

Long-term visual outcome in patients treated by flow diversion for carotid-ophthalmic aneurysms.

机构信息

Departement of Neuroradiology, Pitié-Salpêtrière Hospital, Paris, France.

Departement of Ophthalmology, Pitié-Salpêtrière Hospital, Paris, France.

出版信息

J Neurointerv Surg. 2018 Nov;10(11):1067-1073. doi: 10.1136/neurintsurg-2017-013684. Epub 2018 Mar 23.

Abstract

BACKGROUND

Flow-diverter stents (FDSs) are an upgrade in the treatment of intracranial aneurysms. However, complications concerning covered branches have been reported, especially the ophthalmic artery (OA). The purpose of our study was to evaluate the long-term ophthalmic complication rate of carotid-ophthalmic aneurysms (COA) without visual pathways compression, treated by a FDS covering the OA by performing an exhaustive ophthalmic examination.

MATERIAL AND METHODS

Retrospective analysis of a single-center database screening the patients treated from October 2009 to April 2015 for an intracranial aneurysm with a FDS. The patients treated for a non-compressive COA with coverage of the OA by the device were studied (n=30). Among these patients, 15 (50%) were excluded. The remaining 15 patients underwent a systematic and extensive ophthalmic examination at least 2 years after the stent placement by two ophthalmologists.

RESULTS

Fifteen patients with 16 COAs treated with a FDS were included. Mean follow-up was 4.1±2 years. Six patients (40%), presented ophthalmic complications, including three fugax amauroses (18.8%) and four significant visual field defects (25%). After comparing each eye's visual field's patients, we observed a significant difference between the eye on the FDS side compared with the contralateral eye, with a mean deviation of -1.58 dB versus -0.67 dB respectively (P=0.003). Visual acuity was preserved in all patients.

CONCLUSION

Patients treated by FDS for COA have a good long-term clinical ophthalmic outcome. However, extensive ophthalmic examination shows a high percentage of minor ophthalmic modifications. Interventional neuroradiologists should be aware of these possible complications when choosing to treat these aneurysms with FDS.

摘要

背景

血流导向装置(FDS)是颅内动脉瘤治疗的一项升级技术。然而,已经报道了与分支血管覆盖相关的并发症,尤其是与眼动脉(OA)相关的并发症。我们的研究目的是通过对接受 FDS 治疗的 OA 覆盖的无视觉通路压迫的颈内-眼动脉动脉瘤(COA)患者进行详尽的眼科检查,评估其长期眼部并发症发生率。

材料和方法

回顾性分析 2009 年 10 月至 2015 年 4 月期间因颅内动脉瘤接受 FDS 治疗的单中心数据库患者。研究对象为接受该装置治疗的非压迫性 COA 且 OA 被覆盖的患者(n=30)。其中,15 例(50%)患者被排除。其余 15 例患者在支架置入后至少 2 年,由两位眼科医生对其进行了系统和广泛的眼科检查。

结果

15 例患者共 16 个 COA 接受了 FDS 治疗,平均随访时间为 4.1±2 年。6 例(40%)患者出现眼部并发症,包括 3 例一过性黑矇(18.8%)和 4 例明显视野缺损(25%)。比较每位患者双眼的视野后,我们观察到 FDS 侧眼与对侧眼之间存在显著差异,平均偏差分别为-1.58dB 和-0.67dB(P=0.003)。所有患者的视力均保持正常。

结论

接受 FDS 治疗 COA 的患者具有良好的长期临床眼部预后。然而,广泛的眼科检查显示出轻微眼部改变的高比例。当选择使用 FDS 治疗这些动脉瘤时,介入神经放射学家应意识到这些可能的并发症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验